ACSL4 and neoplasm: Additionally, in both breast tumor cells and animal models, the use of PRGL493, a chemical inhibitor of ACSL4 impeding de novo steroid synthesis, could block cell proliferation and tumor growth, and promote the sensitivity of tumor cells to chemotherapeutic and hormonal treatment (Castillo et al., 2021).